Concord Biotech Limited
CONCORDBIO.NS- 1D
- -0.7%
Concord Biotech Limited in brief
Concord Biotech Limited is a listed company in the Healthcare sector, based in India. Its market value was $1.2 B on 19 November 2026, which makes it the 8,316th largest listed company in the world and the 557th largest in India on this site.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Concord Biotech Limited timeline
- 2023
- 📈Listed on National Stock Exchange of India as CONCORDBIOFirst day of listing in the exchange's official list.
Events of Concord Biotech Limited from the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Concord Biotech Limited share price · NSE (CONCORDBIO.NS)
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Nov 19, 2026 | 556.00 | 561.00 | 549.10 | 556.40 | -0.8% | 272,032 |
| Nov 18, 2026 | 546.80 | 566.30 | 545.90 | 561.00 | +1.1% | 570,378 |
| Nov 17, 2026 | 584.40 | 584.40 | 553.50 | 554.80 | -4.5% | 690,494 |
| Nov 16, 2026 | 595.70 | 596.00 | 577.90 | 581.00 | -2.2% | 331,037 |
| Nov 13, 2026 | 604.30 | 612.00 | 588.70 | 594.00 | -1.3% | 154,642 |
| Nov 12, 2026 | 600.00 | 604.40 | 595.80 | 601.80 | +0.8% | 196,543 |
| Nov 11, 2026 | 607.80 | 614.10 | 594.90 | 597.20 | +0.1% | 244,658 |
| Nov 9, 2026 | 615.00 | 625.20 | 592.50 | 596.80 | -5.7% | 413,912 |
| Nov 6, 2026 | 656.00 | 663.00 | 622.30 | 632.60 | -6.0% | 259,305 |
| Nov 5, 2026 | 660.00 | 684.00 | 654.00 | 672.70 | +2.6% | 372,203 |
| Nov 4, 2026 | 608.00 | 662.00 | 594.60 | 655.50 | -46.6% | 355,637 |
| Nov 3, 2026 | 1,173 | 1,248 | 1,167 | 1,228 | +5.5% | 337,197 |
| Nov 2, 2026 | 1,208 | 1,210 | 1,156 | 1,164 | -6.6% | 408,684 |
| Oct 30, 2026 | 1,224 | 1,272 | 1,215 | 1,246 | +1.2% | 103,692 |
| Oct 29, 2026 | 1,265 | 1,281 | 1,227 | 1,231 | -3.0% | 174,733 |
| Oct 28, 2026 | 1,320 | 1,333 | 1,263 | 1,269 | -7.8% | 380,222 |
| Oct 27, 2026 | 1,309 | 1,394 | 1,298 | 1,375 | +4.9% | 157,342 |
| Oct 26, 2026 | 1,225 | 1,325 | 1,225 | 1,311 | +6.7% | 185,480 |
| Oct 23, 2026 | 1,271 | 1,280 | 1,213 | 1,229 | -3.3% | 96,706 |
| Oct 22, 2026 | 1,270 | 1,309 | 1,253 | 1,271 | +0.1% | 93,347 |
| Oct 21, 2026 | 1,267 | 1,284 | 1,251 | 1,270 | -1.2% | 83,316 |
| Oct 19, 2026 | 1,350 | 1,350 | 1,276 | 1,286 | -4.0% | 79,842 |
| Oct 16, 2026 | 1,363 | 1,367 | 1,332 | 1,339 | -1.1% | 45,381 |
| Oct 15, 2026 | 1,391 | 1,395 | 1,350 | 1,353 | -2.1% | 35,984 |
| Oct 14, 2026 | 1,379 | 1,396 | 1,372 | 1,382 | +0.9% | 63,724 |
| Oct 13, 2026 | 1,355 | 1,375 | 1,336 | 1,370 | +1.1% | 67,678 |
| Oct 12, 2026 | 1,368 | 1,389 | 1,350 | 1,354 | -0.5% | 53,163 |
| Oct 9, 2026 | 1,336 | 1,370 | 1,326 | 1,361 | +2.3% | 128,354 |
| Oct 8, 2026 | 1,360 | 1,371 | 1,310 | 1,331 | -2.1% | 181,142 |
| Oct 7, 2026 | 1,373 | 1,380 | 1,356 | 1,360 | — | 43,657 |
Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.
Concord Biotech Limited share price statistics
Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.
Market cap history
World rank over time
Rank in India: #541 (Nov 2026) · #543 (Nov 2026) · #543 (Nov 2026) · #562 (Nov 2026) · #557 (Nov 2026) · #557 (Nov 2026)
Mutual funds holding Concord Biotech Limited#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇮🇳 DSP Small Cap FundDSP Asset Managers | 2.62 M | $34 M | — | 1.6% | no change | Oct 31, 2026 |
| 🇮🇳 SBI Healthcare Opportunities FundSBI Funds Management | 960,000 | $13 M | — | 2.0% | no change | Oct 31, 2026 |
| 🇮🇳 DSP Healthcare FundDSP Asset Managers | 735,820 | $10 M | — | 2.5% | no change | Oct 31, 2026 |
| 🇺🇸 Aberdeen India Fund, Inc.ABRDN Asia Limited | 460,707 | $6 M | — | 1.1% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Total International Stock Index FundThe Vanguard Group, Inc. | 397,583 | $6 M | — | <0.01% | +3.9% | Jul 31, 2026 |
| 🇺🇸 Vanguard Emerging Markets Stock Index FundThe Vanguard Group, Inc. | 361,053 | $5 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 iShares Core MSCI Emerging Markets ETFBlackRock Fund Advisors | 283,390 | $3 M | — | <0.01% | +27% | May 31, 2026 |
| 🇺🇸 Vanguard Ftse All-World Ex-Us Small-Cap Index FundThe Vanguard Group, Inc. | 115,718 | $2 M | — | 0.01% | +4401% | Jul 31, 2026 |
| 🇮🇳 SBI Balanced Hybrid FundSBI Funds Management | 120,000 | $2 M | — | 0.75% | no change | Oct 31, 2026 |
| 🇮🇳 Nippon India Pharma FundNippon Life India Asset Management | 111,738 | $1 M | — | 0.15% | no change | Oct 31, 2026 |
| 🇮🇳 Nippon India Nifty Smallcap 250 Index FundNippon Life India Asset Management | 49,074 | $1 M | — | 0.20% | −4.0% | Oct 31, 2026 |
| 🇺🇸 WisdomTree India Earnings FundWisdomTree Asset Management, Inc. | 38,578 | $1 M | — | 0.02% | −5.6% | Jun 30, 2026 |
| 🇺🇸 iShares MSCI India Small-Cap ETFBlackRock Fund Advisors | 45,634 | $1 M | — | 0.08% | −8.7% | May 31, 2026 |
| 🇺🇸 State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc. | 32,437 | $0 M | — | 0.06% | −2.9% | Jun 30, 2026 |
| 🇮🇳 SBI Nifty Smallcap 250 Index FundSBI Funds Management | 26,140 | $0 M | — | 0.20% | +0.7% | Oct 31, 2026 |
| 🇺🇸 Vanguard Total World Stock Index FundThe Vanguard Group, Inc. | 19,807 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇮🇳 Motilal Oswal Nifty Smallcap 250 Index FundMotilal Oswal Asset Management | 18,419 | $0 M | — | 0.20% | +0.0% | Oct 31, 2026 |
| 🇺🇸 WisdomTree Emerging Markets SmallCap Dividend FundWisdomTree Asset Management, Inc. | 13,381 | $0 M | — | 0.01% | −1.1% | Jun 30, 2026 |
| 🇺🇸 Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP | 10,847 | $0 M | — | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Core Equity Market ETFDimensional Fund Advisors LP | 7,968 | $0 M | — | <0.01% | +9.1% | Jul 31, 2026 |
| 🇺🇸 State Street Global All Cap Equity ex-U.S. Index PortfolioSSGA Funds Management, Inc. | 8,583 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC | 8,412 | $0 M | — | <0.01% | −57% | Jun 30, 2026 |
| 🇺🇸 The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP | 7,295 | $0 M | — | <0.01% | new | Jul 31, 2026 |
| 🇮🇳 Nippon India Nifty 500 Equal Weight Index FundNippon Life India Asset Management | 6,387 | $0 M | — | 0.18% | +0.7% | Oct 31, 2026 |
| 🇺🇸 Emerging Markets Social Core Equity PortfolioDimensional Fund Advisors LP | 5,502 | $0 M | — | <0.01% | +25% | Jul 31, 2026 |
| 🇺🇸 iShares MSCI Emerging Markets Small-Cap ETFBlackRock Fund Advisors | 7,257 | $0 M | — | 0.02% | no change | May 31, 2026 |
| 🇮🇳 Motilal Oswal Nifty 500 Index FundMotilal Oswal Asset Management | 5,421 | $0 M | — | 0.02% | +2.0% | Oct 31, 2026 |
| 🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 4,053 | $0 M | — | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Vanguard Esg International Stock ETFThe Vanguard Group, Inc. | 4,855 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇮🇳 Motilal Oswal Nifty Smallcap 250 ETFMotilal Oswal Asset Management | 3,662 | $0 M | — | 0.20% | −1.3% | Oct 31, 2026 |
| 🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP | 3,218 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Sustainability Core 1 ETFDimensional Fund Advisors LP | 2,198 | $0 M | — | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Emerging Markets ex China Core Equity PortfolioDimensional Fund Advisors LP | 2,052 | $0 M | — | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 FlexShares Morningstar Emerging Markets Factor Tilt Index FundNorthern Trust Investments, Inc. | 1,288 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇮🇳 SBI Nifty 500 Index FundSBI Funds Management | 1,283 | $0 M | — | 0.02% | +1.6% | Oct 31, 2026 |
| 🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP | 897 | $0 M | — | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets ex China Core Equity ETFDimensional Fund Advisors LP | 692 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Avantis Emerging Markets Small Cap Equity ETFAmerican Century ETF Trust | 831 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇮🇳 Motilal Oswal Nifty 500 ETFMotilal Oswal Asset Management | 514 | $0 M | — | 0.02% | no change | Oct 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Oct 31, 2026. The 39 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Where Concord Biotech Limited operates: 1 country#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.
Only the headquarters country is on file for Concord Biotech Limited: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.
| Country | Presence | Revenue there |
|---|---|---|
| 🇮🇳 India | Headquarters | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
FDA drug approvals: Concord Biotech Limited#
5 approved applications held; 1 approvals and 0 new uses in 2026.
| Approved | Drug | Kind |
|---|---|---|
| 2026-06-09 | Tofacitinib CitrateTofacitinib Citrate · ANDA218821 | Generic drug (ANDA) |
| 2020-11-10 | TacrolimusTacrolimus · ANDA213112 | Generic drug (ANDA) |
| 2020-07-31 | Mycophenolate MofetilMycophenolate Mofetil · ANDA212087 | Generic drug (ANDA) |
| 2019-12-13 | Mycophenolate SodiumMycophenolate Sodium · ANDA211173 | Generic drug (ANDA) |
| 2019-01-08 | Mycophenolate MofetilMycophenolate Mofetil · ANDA210181 | Generic drug (ANDA) |
Source: Drugs@FDA (openFDA). Approvals are listed under the application's current holder (CONCORD BIOTECH LTD), so they follow acquisitions
Discuss Concord Biotech Limited#
1 automatic updates and 0 member comments. Sign in to comment and react.
- Mutual funds: 39 funds hold $87 millionautomatic update · Oct 31, 2026
39 mutual funds in 2 countries hold shares of Concord Biotech Limited worth $87 million (funds' newest reports, up to 31 October 2026). Since their previous reports 16 funds added shares and 7 sold; on balance they bought $3 million. Share splits are not counted as trading.
How Concord Biotech Limited compares in Healthcare
- Market cap$1.2 B · higher than 63% of 2,013
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Concord Biotech Limited🇮🇳 | $1.2 B | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
Sources and freshness
- Market cap:
- Nov 19, 2026
- Profile updated:
- Nov 20, 2026
Figures from Market data, value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Concord Biotech Limited? Verify and update this profile — free
Show Concord Biotech Limited's ranking on your website Get the badge
The badge updates itself as the ranking changes.